JP2020517727A5 - - Google Patents

Download PDF

Info

Publication number
JP2020517727A5
JP2020517727A5 JP2019558668A JP2019558668A JP2020517727A5 JP 2020517727 A5 JP2020517727 A5 JP 2020517727A5 JP 2019558668 A JP2019558668 A JP 2019558668A JP 2019558668 A JP2019558668 A JP 2019558668A JP 2020517727 A5 JP2020517727 A5 JP 2020517727A5
Authority
JP
Japan
Prior art keywords
preparation according
cannabidiol
concentration
vehicle
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019558668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020517727A (ja
Filing date
Publication date
Priority claimed from US15/499,178 external-priority patent/US12544389B2/en
Application filed filed Critical
Priority claimed from PCT/US2017/052897 external-priority patent/WO2018200024A1/en
Publication of JP2020517727A publication Critical patent/JP2020517727A/ja
Publication of JP2020517727A5 publication Critical patent/JP2020517727A5/ja
Priority to JP2022089421A priority Critical patent/JP2022130390A/ja
Priority to JP2024113145A priority patent/JP2024161363A/ja
Priority to JP2025077148A priority patent/JP2025118786A/ja
Priority to JP2025077149A priority patent/JP2025118787A/ja
Pending legal-status Critical Current

Links

JP2019558668A 2017-04-27 2017-09-22 安定なカンナビノイド製剤 Pending JP2020517727A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2022089421A JP2022130390A (ja) 2017-04-27 2022-06-01 安定なカンナビノイド製剤
JP2024113145A JP2024161363A (ja) 2017-04-27 2024-07-16 安定なカンナビノイド製剤
JP2025077148A JP2025118786A (ja) 2017-04-27 2025-05-07 安定なカンナビノイド製剤
JP2025077149A JP2025118787A (ja) 2017-04-27 2025-05-07 安定なカンナビノイド製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/499,178 2017-04-27
US15/499,178 US12544389B2 (en) 2014-05-29 2017-04-27 Stable cannabinoid formulations
PCT/US2017/052897 WO2018200024A1 (en) 2017-04-27 2017-09-22 Stable cannabinoid formulations

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2022089421A Division JP2022130390A (ja) 2017-04-27 2022-06-01 安定なカンナビノイド製剤
JP2024113145A Division JP2024161363A (ja) 2017-04-27 2024-07-16 安定なカンナビノイド製剤

Publications (2)

Publication Number Publication Date
JP2020517727A JP2020517727A (ja) 2020-06-18
JP2020517727A5 true JP2020517727A5 (https=) 2020-11-12

Family

ID=63920361

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2019558668A Pending JP2020517727A (ja) 2017-04-27 2017-09-22 安定なカンナビノイド製剤
JP2022089421A Pending JP2022130390A (ja) 2017-04-27 2022-06-01 安定なカンナビノイド製剤
JP2024113145A Pending JP2024161363A (ja) 2017-04-27 2024-07-16 安定なカンナビノイド製剤
JP2025077148A Pending JP2025118786A (ja) 2017-04-27 2025-05-07 安定なカンナビノイド製剤
JP2025077149A Pending JP2025118787A (ja) 2017-04-27 2025-05-07 安定なカンナビノイド製剤

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2022089421A Pending JP2022130390A (ja) 2017-04-27 2022-06-01 安定なカンナビノイド製剤
JP2024113145A Pending JP2024161363A (ja) 2017-04-27 2024-07-16 安定なカンナビノイド製剤
JP2025077148A Pending JP2025118786A (ja) 2017-04-27 2025-05-07 安定なカンナビノイド製剤
JP2025077149A Pending JP2025118787A (ja) 2017-04-27 2025-05-07 安定なカンナビノイド製剤

Country Status (4)

Country Link
EP (2) EP4516355A3 (https=)
JP (5) JP2020517727A (https=)
CA (1) CA3062814C (https=)
WO (1) WO2018200024A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12544389B2 (en) 2014-05-29 2026-02-10 Fresh Cut Development, Llc Stable cannabinoid formulations
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
CA3062814C (en) * 2017-04-27 2023-11-14 Insys Development Company, Inc. Stable cannabinoid formulations
GB2568929A (en) 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
CN117695226A (zh) 2018-12-11 2024-03-15 迪斯拉普申实验室公司 用于递送治疗剂的组合物及其使用方法和制备方法
GB2584140A (en) * 2019-05-23 2020-11-25 Gw Res Ltd Use of cannabidiol in the treatment of epileptic spasms
US20220347118A1 (en) * 2019-09-09 2022-11-03 Cardiol Therapeutics Inc. Stable medicinal cannabidiol compositions
GB2588461A (en) * 2019-10-25 2021-04-28 Gw Res Ltd Use of cannabidiol preparations in the treatment of absence epilepsy
US20220401380A1 (en) * 2019-10-25 2022-12-22 Cardiol Therapeutics Inc. Cannabidiol compositions for use in treating heart conditions
TW202231192A (zh) * 2020-09-24 2022-08-16 英商尼可創業貿易有限公司 包裝調配物
JP2023546649A (ja) * 2020-09-24 2023-11-07 ニコベンチャーズ トレーディング リミテッド 製剤
JP2024528569A (ja) * 2021-07-13 2024-07-30 イーピーエム（アイピー）， インコーポレイテッド プラダー・ウィリー症候群を治療するためのカンナビジオール酸エステル
US20250025482A1 (en) * 2021-07-28 2025-01-23 GW Research Limited Use of cannabidiol in the treatment of epilepsy
AU2023361756A1 (en) * 2022-10-12 2025-05-22 Leiutis Pharmaceuticals Llp Novel liquid oral formulations of cannabidiol
CN115887426A (zh) * 2022-11-18 2023-04-04 中国人民解放军军事科学院军事医学研究院 大麻二酚在制备核辐射损伤后骨髓恢复药物中的应用
CN116444351A (zh) * 2022-11-18 2023-07-18 中国人民解放军军事科学院军事医学研究院 一种核辐射损伤中对小肠有保护作用的天然小分子化合物
CN116172988A (zh) * 2022-11-18 2023-05-30 中国人民解放军军事科学院军事医学研究院 大麻二酚用于制备急性放射病的药物的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2576505A1 (en) * 2004-08-03 2006-02-16 Orexigen Therapeutics, Inc. Combination of bupropion and a second compound for affecting weight loss
MX2008006550A (es) * 2005-11-23 2008-09-23 Ironwood Pharmaceuticals Inc Metodos y composiciones para el tratamiento de trastornos gastrointestinales.
GB2438682A (en) * 2006-06-01 2007-12-05 Gw Pharma Ltd New use for cannabinoids
WO2011057199A1 (en) * 2009-11-06 2011-05-12 Adenios, Inc. Compositions for treating cns disorders
WO2011150338A1 (en) * 2010-05-27 2011-12-01 Zafgen Corporation Methods of treating obesity
US20160367496A1 (en) 2014-05-29 2016-12-22 Insys Development Company, Inc. Stable cannabinoid formulations
US20160271252A1 (en) * 2014-05-29 2016-09-22 Insys Development Company, Inc. Stable cannabinoid formulations
US11331279B2 (en) * 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
EP4151234A1 (en) * 2014-05-29 2023-03-22 Fresh Cut Development, LLC Stable cannabinoid formulations
CA2986268C (en) 2015-05-28 2024-01-02 Insys Development Company, Inc. Stable cannabinoid formulations
CA3062814C (en) * 2017-04-27 2023-11-14 Insys Development Company, Inc. Stable cannabinoid formulations

Similar Documents

Publication Publication Date Title
JP2020517727A5 (https=)
JP7374951B2 (ja) 安定なカンナビノイド製剤
RU2017126039A (ru) САМОЭМУЛЬГИРУЮЩАЯСЯ КОМПОЗИЦИЯ ω3 ЖИРНОЙ КИСЛОТЫ
JP2018521042A5 (https=)
JP2013511496A5 (https=)
JP2013521310A5 (https=)
BG108071A (bg) Есенциални мастни n-3-киселини в лечението на сърдечна недостатъчност и сърдечна слабост
ES2759448T3 (es) Composiciones que comprenden 15-HEPE y métodos de uso de las mismas
CN104640573B (zh) 萝卜硫烷的分离和纯化
JP2014528474A5 (https=)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
JP2016515530A5 (https=)
JP2015530382A5 (https=)
JP2014515407A5 (https=)
JP6605047B2 (ja) 疼痛治療のためのセレコキシブの経口用組成物
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2012533565A5 (https=)
JP2020514282A5 (https=)
JP2015522015A5 (https=)
WO2015155544A1 (en) Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders
CN103338761A (zh) 抗癌剂所引起的周围神经病的预防或治疗剂
WO2015047982A3 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
RU2010138650A (ru) Комбинация, включающая паклитаксел, для лечения рака яичников
JP2016512247A5 (https=)
RU2014141112A (ru) Метаболит илоперидона для применения при лечении психических расстройств